U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

WHO Guidelines for malaria [Internet]. Geneva: World Health Organization; 2022 Feb 18.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of WHO Guidelines for malaria

WHO Guidelines for malaria [Internet].

Show details

AnnexAll evidence profiles, sorted by sections

  1. ABBREVIATIONS
  2. EXECUTIVE SUMMARY
  3. INTRODUCTION
  4. PREVENTION
    4.1.

    Vector control

    4.1.1.

    Interventions recommended for large-scale deployment

    Download PDF (250K)

    4.1.2.

    Combining ITNs and IRS

    Download PDF (167K)

    4.1.3.

    Supplementary interventions

    Download PDF (283K)

    4.1.4.

    Other considerations for vector control

    4.1.4.1.

    Special situations

    4.1.4.2.

    Implementation challenges

    4.1.4.3.

    Monitoring and evaluation of vector control

    4.1.5.

    Research needs

    4.2.

    Preventive chemotherapies & Mass drug administration

    4.2.1.

    Intermittent preventive treatment of malaria in pregnancy (IPTp)

    Download PDF (167K)

    4.2.2.

    Intermittent preventive treatment of malaria in infants (IPTi)

    4.2.3.

    Seasonal malaria chemoprevention (SMC)

    Download PDF (148K)

    4.3.

    Vaccine

    Download PDF (333K)

  5. CASE MANAGEMENT
    5.1.

    Diagnosing malaria (2015)

    5.2.

    Treating uncomplicated malaria

    5.2.1.

    Artemisinin-based combination therapy

    Download PDF (439K)

    5.2.2.

    Duration of treatment

    Download PDF (152K)

    5.2.3.

    Dosing of ACTS

    5.2.4.

    Recurrent falciparum malaria

    5.2.5.

    Reducing the transmissibility of treated P. falciparum infections in areas of low-intensity transmission

    Download PDF (150K)

    5.3.

    Treating special risk groups

    5.3.1.

    Pregnant and lactating women

    5.3.2.

    Young children and infants

    5.3.3.

    Patients co-infected with HIV

    5.3.4.

    Non-immune travellers

    5.3.5.

    Uncomplicated hyperparasitaemia

    5.4.

    Treating uncomplicated malaria caused by P. vivax, P. ovale, P. malariae or P. knowlesi

    Download PDF (204K)

    5.5.

    Treating severe malaria

    5.5.1.

    Artesunate

    Download PDF (165K)

    5.5.2.

    Parenteral alternatives when artesunate is not available

    Download PDF (181K)

    5.5.3.

    Pre-referral treatment options

    Download PDF (149K)

    5.6.

    Other considerations in treating malaria

    5.6.1.

    Management of malaria cases in special situations

    5.6.2.

    Quality of antimalarial drugs

    5.6.3.

    Monitoring efficacy and safety of antimalarial drugs and resistance

    5.7.

    National adaptation and implementation

  6. ELIMINATION
  7. SURVEILLANCE
  8. METHODS
  9. GLOSSARY
  10. CONTRIBUTORS AND INTERESTS
    10.1.

    Guidelines for malaria vector control

    10.2.

    Malaria vaccine recommendation

    10.3.

    Guidelines for the treatment of malaria

© World Health Organization 2022.

Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.

Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.

Some rights reserved. This work is available under the Creative Commons AttributionNonCommercial-ShareAlike 3.0 IGO license (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).

Under the terms of this license, you may copy, redistribute and adapt the work for noncommercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons license. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”.

Any mediation relating to disputes arising under the license shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.

Bookshelf ID: NBK579019

Views

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...